Manli Cui

机构：Dalian Medical University, Xi'an Medical University, First Affiliated Hospital of Dalian Medical University · ORCID：0000-0001-7860-2472

发表论文 43 篇 · 总被引 463 次 · h-index 12

代表论文

• Oral carbon dot nanozymes with red fluorescence and superoxide dismutase-like activity for colitis bioimaging and inflammation management (2024 · Chemical Engineering Journal · 被引 63)
• Oral Nanotherapeutics of Andrographolide/Carbon Monoxide Donor for Synergistically Anti-inflammatory and Pro-resolving Treatment of Ulcerative Colitis (2023 · ACS Applied Materials & Interfaces · 被引 40)
• Medicinal Plant-Derived Carbon Dots Nanozymes Ameliorate Ulcerative Colitis via Anti-inflammatory, Antioxidant, and Gut Barrier-Protective Effects (2025 · ACS Applied Materials & Interfaces · 被引 33)
• Oral administration of Momordica charantia-derived extracellular vesicles alleviates ulcerative colitis through comprehensive renovation of the intestinal microenvironment (2025 · Journal of Nanobiotechnology · 被引 26)
• MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancer (2023 · Cancer Gene Therapy · 被引 25)
• New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites (2025 · Computational and Structural Biotechnology Journal · 被引 22)